{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:27:03Z","timestamp":1791962823169,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.yexmp.2017.01.016","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T12:22:28Z","timestamp":1486038148000},"page":"198-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions"],"prefix":"10.1016","volume":"102","author":[{"given":"Harsha S.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Dirk","family":"Keene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Jian-Amadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-4502","authenticated-orcid":false,"given":"Patrick J.","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2017.01.016_bb0005","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/35020115","article-title":"Molecular classification of cutaneous malignant melanoma by gene expression profiling","volume":"406","author":"Bittner","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2017.01.016_bb0010","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/cncr.10986","article-title":"A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1","volume":"95","author":"Cheah","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2017.01.016_bb0015","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nchembio.137","article-title":"Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer","volume":"5","author":"Chen","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0020","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/jid.2008.445","article-title":"A Wnt survival guide: from flies to human disease","volume":"129","author":"Chien","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1073\/pnas.0811902106","article-title":"Activated Wnt\/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model","volume":"106","author":"Chien","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/bjo.82.11.1316","article-title":"MIB-1 and PC-10 immunostaining for the assessment of proliferative activity in primary acquired melanosis without and with atypia","volume":"82","author":"Chowers","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.yexmp.2016.05.002","article-title":"Mutational status of IDH1 in uveal melanoma","volume":"100","author":"Cimino","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0040","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1442-9071.2008.01888.x","article-title":"Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging","volume":"36","author":"Damato","year":"2008","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0045","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archophthalmol.2009.183","article-title":"WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases","volume":"127","author":"Furusato","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0050","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00008390-200008000-00006","article-title":"Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45","volume":"10","author":"Heegaard","year":"2000","journal-title":"Melanoma Res."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0055","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2008-1034978","article-title":"Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva","volume":"213","author":"Hitzer","year":"1998","journal-title":"Klin. Monatsbl. Augenheilkd."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0060","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/archopht.120.12.1625","article-title":"Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas","volume":"120","author":"Iwamoto","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0161-6420(89)32920-4","article-title":"Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva","volume":"96","author":"Jakobiec","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.yexmp.2017.01.016_bb0070","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archophthalmol.2009.171","article-title":"Immunohistochemical studies of atypical conjunctival melanocytic nevi","volume":"127","author":"Jakobiec","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archophthalmol.2009.394","article-title":"Immunohistochemical studies of conjunctival nevi and melanomas","volume":"128","author":"Jakobiec","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-2133.2001.04336.x","article-title":"Loss of beta-catenin expression associated with disease progression in malignant melanoma","volume":"145","author":"Kageshita","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2005.080390","article-title":"Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions","volume":"90","author":"Keijser","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/01.pai.0000209868.58699.64","article-title":"The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions","volume":"15","author":"Lebe","year":"2007","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0095","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/00000478-200210000-00012","article-title":"Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma","volume":"26","author":"Lohmann","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0039-6257(97)00122-7","article-title":"Conjunctival melanoma","volume":"42","author":"Seregard","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0105","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1365-2559.2001.01168.x","article-title":"Differential immunoreactivity of melanocytic lesions of the conjunctiva","volume":"39","author":"Sharara","year":"2001","journal-title":"Histopathology"},{"issue":"511\u2013519","key":"10.1016\/j.yexmp.2017.01.016_bb0110","article-title":"Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture","volume":"115","author":"Shields","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.yexmp.2017.01.016_bb0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/CMR.0000000000000197","article-title":"Identification and clinical relevance of PD-L1 expression in primary mucosal malignant melanoma of the head and neck","volume":"25","author":"Thierauf","year":"2015","journal-title":"Melanoma Res."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0120","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/bjo.2010.183939","article-title":"Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma","volume":"95","author":"Westekemper","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0125","doi-asserted-by":"crossref","first-page":"14235","DOI":"10.1007\/s13277-016-5293-6","article-title":"Targeted deactivation of cancer-associated fibroblasts by beta-catenin ablation suppresses melanoma growth","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.yexmp.2017.01.016_bb0130","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bjo.2008.147355","article-title":"Tumour-associated lymphangiogenesis in conjunctival malignant melanoma","volume":"93","author":"Zimmermann","year":"2009","journal-title":"Br. J. Ophthalmol."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480017300606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480017300606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T13:34:38Z","timestamp":1536068078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480017300606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0014480017300606"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.01.016","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2017.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}